
Subi Medicaments Private Limited
Founded in 2020 and headquartered in Madhya Pradesh, India.
Founded in 2020 and headquartered in Madhya Pradesh, India.
Indore, Madhya Pradesh, India
+91-XXXXXXXXXX
U24239MP2020PTC053545
053545
Private Limited Indian Non-Government Company
02 Nov 2020
-
-
Unlisted
Roc Gwalior
Name | Designation | Appointment Date | Status |
---|---|---|---|
Akshay Agrawal ![]() | Director | 02-Nov-2020 | Current |
Jyothi Vyas ![]() | Director | 02-Nov-2020 | Current |
Enhance accessibility to Subi Medicaments's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Subi Medicaments's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Jyothi Vyas is a mutual person
Jyothi Vyas is a mutual person
There are no open charges registered against the company as per our records.
Subi Medicaments has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Subi Medicaments, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Subi Medicaments's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Akshay Agrawal was appointed as a Director was appointed as a Director on 02 Nov 2020 & has been associated with this company since 4 years 6 months .
Jyothi Vyas was appointed as a Director was appointed as a Director on 02 Nov 2020 & has been associated with this company since 4 years 6 months .
Subi Medicaments Private Limited was registered on 02 Nov 2020 with Roc Gwalior & aged 4 years 6 months as per MCA records.
Subi Medicaments Private Limited was incorporated on 02 Nov 2020.
The authorized share capital of Subi Medicaments Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.10 M.
Currently 2 directors are associated with Subi Medicaments Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Subi Medicaments Private Limited is 63, Vaishno Vihar Schme No. 51 India, Indore, Madhya Pradesh, 452001.
The corporate identification number (CIN) of Subi Medicaments Private Limited is U24239MP2020PTC053545 and the company number is 053545 as per Ministry of Corporate Affairs (MCA).
Search company & director profiles for free and gain access to critical business data.